PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Assembly Biosciences, Inc. (ASMB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US0453961080

CUSIP

045396108

Sector

Healthcare

IPO Date

Dec 17, 2010

Highlights

Market Cap

$79.33M

EPS (TTM)

-$6.89

Total Revenue (TTM)

$21.16M

Gross Profit (TTM)

$21.10M

EBITDA (TTM)

-$33.79M

Year Range

$11.05 - $19.93

Target Price

$35.50

Short %

0.32%

Short Ratio

0.52

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Assembly Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-14.95%
9.05%
ASMB (Assembly Biosciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Assembly Biosciences, Inc. had a return of -20.91% year-to-date (YTD) and 9.09% in the last 12 months. Over the past 10 years, Assembly Biosciences, Inc. had an annualized return of -23.46%, while the S&P 500 had an annualized return of 11.29%, indicating that Assembly Biosciences, Inc. did not perform as well as the benchmark.


ASMB

YTD

-20.91%

1M

-13.87%

6M

-13.99%

1Y

9.09%

5Y*

-45.39%

10Y*

-23.46%

^GSPC (Benchmark)

YTD

4.22%

1M

2.22%

6M

9.51%

1Y

22.46%

5Y*

12.74%

10Y*

11.29%

*Annualized

Monthly Returns

The table below presents the monthly returns of ASMB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-11.22%-20.91%
202414.63%13.37%3.99%-6.24%21.49%-9.44%6.45%11.33%-6.89%11.03%1.37%-7.39%60.35%
202333.85%-21.84%-38.21%23.75%-7.90%20.07%-3.48%-10.82%-10.60%-0.92%-20.16%17.14%-36.92%
2022-20.17%-16.67%32.90%-14.56%8.52%9.95%-1.43%-9.66%-12.30%-0.00%-20.12%-0.76%-44.21%
2021-7.77%-8.96%-9.45%-6.96%-7.24%-2.27%-10.57%9.51%-8.42%-9.48%-26.98%1.30%-61.49%
2020-14.17%3.19%-18.16%18.07%11.31%19.65%-4.80%-1.49%-24.83%-10.34%-60.89%4.94%-70.43%
20190.71%-6.10%-7.95%-19.86%-11.03%-3.92%-7.34%-9.52%-13.09%67.96%-1.76%26.14%-9.55%
20184.27%20.26%-13.39%-11.52%-2.74%-7.28%12.80%-9.56%-7.15%-38.40%12.67%-12.26%-50.01%
201752.84%12.33%22.20%-7.30%7.53%-18.73%8.52%20.97%28.81%-15.49%69.13%-9.34%272.43%
2016-31.82%-11.33%10.57%19.52%-4.83%-2.80%0.72%9.30%18.00%95.84%-8.99%-5.45%61.78%
20156.87%60.83%-2.00%0.60%25.08%15.61%-22.12%-8.60%-30.27%0.42%2.40%-23.60%-4.45%
201410.99%-67.92%-6.25%-16.08%17.76%3.97%-3.36%14.69%12.81%-0.00%0.85%-4.84%-58.85%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ASMB is 48, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ASMB is 4848
Overall Rank
The Sharpe Ratio Rank of ASMB is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of ASMB is 4747
Sortino Ratio Rank
The Omega Ratio Rank of ASMB is 4545
Omega Ratio Rank
The Calmar Ratio Rank of ASMB is 4848
Calmar Ratio Rank
The Martin Ratio Rank of ASMB is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Assembly Biosciences, Inc. (ASMB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ASMB, currently valued at 0.11, compared to the broader market-2.000.002.004.000.111.77
The chart of Sortino ratio for ASMB, currently valued at 0.61, compared to the broader market-6.00-4.00-2.000.002.004.006.000.612.39
The chart of Omega ratio for ASMB, currently valued at 1.07, compared to the broader market0.501.001.502.001.071.32
The chart of Calmar ratio for ASMB, currently valued at 0.07, compared to the broader market0.002.004.006.000.072.66
The chart of Martin ratio for ASMB, currently valued at 0.44, compared to the broader market0.0010.0020.0030.000.4410.85
ASMB
^GSPC

The current Assembly Biosciences, Inc. Sharpe ratio is 0.11. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Assembly Biosciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.11
1.77
ASMB (Assembly Biosciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Assembly Biosciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-98.97%
0
ASMB (Assembly Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Assembly Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Assembly Biosciences, Inc. was 99.36%, occurring on Nov 22, 2023. The portfolio has not yet recovered.

The current Assembly Biosciences, Inc. drawdown is 98.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.36%May 10, 20113157Nov 22, 2023
-18.62%Apr 6, 20115Apr 12, 20113Apr 15, 20118
-14.29%Jan 7, 201110Jan 21, 201120Feb 18, 201130
-11.37%Mar 16, 20114Mar 21, 20118Mar 31, 201112
-6.41%Mar 2, 20114Mar 7, 20112Mar 9, 20116

Volatility

Volatility Chart

The current Assembly Biosciences, Inc. volatility is 15.53%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
15.53%
3.19%
ASMB (Assembly Biosciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Assembly Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Assembly Biosciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab